// App-Quantinova.ai

4420 : Heparan sulfate proteoglycans mediate SW13 oncogenic potential and response to granulin

Researchers

Presenter

  • McKale Davis

Principal Investigators

  • Elizabeth Hull

Medical Centers

  • Midwestern University AZCOM, Glendale, AZ

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Cluster of Differentiation 44

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved